CARDIOTOXICIDADE AGUDA GRAVE POR ANTRACICLINA NA INDUÇÃO DE LEUCEMIA PROMIELOCÍTICA AGUDA
M.R. Costa +9 more
openaire +2 more sources
Brazilian Society of Cardiology Guideline on Myocarditis - 2022. [PDF]
Montera MW +44 more
europepmc +1 more source
Empleo de fármacos derivados de las antraciclinas como agentes anticancerígenos
Universidad de Sevilla.
openaire +2 more sources
Surprising Cardiac Magnetic Resonance Imaging Findings: Rapidly Developing Intracardiac Thrombus with Endomyocardial Fibrosis. [PDF]
Bulburu İB +3 more
europepmc +1 more source
[Cardiovascular evaluation of patients undergoing cancer treatments at a clinic for childhood cancer survivors in Mexico]. [PDF]
Jiménez-Carbajal MG +3 more
europepmc +1 more source
[Acute cardiovascular complications in a Peruvian population of oncology patients]. [PDF]
Valenzuela-Rodríguez G +4 more
europepmc +1 more source
Chemotherapy-induced cardiotoxicity in cancer patients: an observational study at an Oncology reference hospital from southeastern Brazil. [PDF]
Neumann K +5 more
europepmc +1 more source
Screening, Diagnosis and Management of Atrial Fibrillation in Cancer Patients: Current Evidence and Future Perspectives. [PDF]
Gonçalves-Teixeira P +9 more
europepmc +1 more source
Introducción: La supervivencia de los pacientes diagnosticados de leucemia aguda linfoblástica se ha incrementado de forma muy llamativa en las últimas décadas desde la introducción de las antraciclinas en los protocolos de tratamiento, siendo actualmente superior al 90%.
openaire +1 more source

